• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Ebola outbreak projected to exceed 20,000 cases by November

byAndrew Cheung, MD MBA
September 24, 2014
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. The outbreak of Ebola has been declared a public health emergency by the World Health Organization.

2. This study reports on data collected in the first 9 months of the outbreak, and suggests that the case-fatality rate in patients with definitive outcomes is 70.8%.

3. The outbreak continues to expand, and is expected to involve more than 20,000 reported cases by early-November 2014.

Evidence Rating Level: 2 (Good)

Study Rundown: The current outbreak of Ebola virus disease (EVD) started in December 2013 in Guinea, and has since spread to Liberia, Nigeria, Senegal, and Sierra Leone. The World Health Organization (WHO) was notified of the worsening outbreak in March 2014, and subsequently declared it a “public health emergency of international concern” on August 8, 2014. As of September 20, 2014, there were 5,843 confirmed, probable, or suspected cases with 2,803 deaths attributed to the current outbreak. It is known that the magnitude of the outbreak is larger than what is captured in official statistics, as many infections and deaths are not documented. Despite widespread efforts to control the outbreak, the number of cases and deaths from EVD continues to rise at a rapid pace.

The purpose of this study is to describe the clinical and epidemiological characteristics of the outbreak in its first 9 months, and to project further spread if control measures are not improved. Based on patients with definitive outcomes, it was calculated that the case-fatality rate was 70.8% (95%CI 68.6-72.8%). Modeling of the spread of infection suggests that the outbreak is still expanding. At current rates of spread and with no change in control efforts, it is estimated that the reported case load will exceed 20,000 by early-November 2014, with the true case load being significantly higher.

Click to read the study, published today in NEJM

RELATED REPORTS

Vaccines for Zaire Ebola virus disease are safe and generate an immune response

The Scan by 2 Minute Medicine®: World Mental Health Day, Beneath the Band-aid, Trouble in Uganda and Carbon Monoxide Leak Sickens Dozens!

2 Minute Medicine Rewind October 16, 2017

Click to read an accompanying editorial, published today in NEJM

Relevant Reading: Ebola haemorrhagic fever

In-Depth [epidemiologic investigation]: Clinical and demographic data were collected using a standard case investigation form, and this was supplemented by information from informal case reports, diagnostic laboratories, and burial records.

This study reports on a total of 4,507 confirmed and probable cases of EVD reported to WHO from December 30, 2013 to September 14, 2014. Notably, 718 confirmed or probable cases and 289 deaths were reported in the most recent week alone. The median age of patients with EVD was 32 years, and the majority of patients were between 15 and 44 years of age (60.8%). The most common symptoms reported were fever (87.1%), fatigue (76.4%), loss of appetite (64.5%), vomiting (67.6%), and diarrhea (65.6%). Hemorrhagic symptoms were rarely reported (<1 to 5.7% of patients), though unexplained bleeding was more common (18.0%).

Case-fatality estimates were challenging to estimate, given that many cases did not have definitive recorded outcomes. In patients with definitive outcomes, case-fatality was calculated to be 70.8% (95%CI 68.6-72.8%), which was consistent among Guinea, Liberia, and Sierra Leone. Significant risk factors for death included age ≥45 years (OR 2.47; 95%CI 1.79-3.46), diarrhea (OR 1.42; 1.06-1.89), and unexplained bleeding (OR 1.83; 95%CI 1.20-2.90), amongst others.

Based on quantification of the spread of infection, it was found that the current outbreak is still expanding, with doubling times of 15.7 days in Guinea, 23.6 days in Liberia, and 30.2 days in Sierra Leone. At the current rates of expansion and with no change in efforts to limit further spread, it is estimated that there will be more than 20,000 cases by November 2, 2014.

Image: PD/CDC

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: ebola
Previous Post

USPSTF recommends counseling for patients at high-risk for STIs

Next Post

Comparison of treatment options for varicose veins [CLASS trial]

RelatedReports

2 Minute Medicine Rewind November 23 – November 30, 2014
Emergency

Vaccines for Zaire Ebola virus disease are safe and generate an immune response

January 4, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: World Mental Health Day, Beneath the Band-aid, Trouble in Uganda and Carbon Monoxide Leak Sickens Dozens!

October 18, 2022
Concomitant HPV vaccine administration equivalent to staggered schedule
Weekly Rewinds

2 Minute Medicine Rewind October 16, 2017

October 25, 2017
Concomitant HPV vaccine administration equivalent to staggered schedule
Infectious Disease

Recombinant vesicular stomatitis virus vaccine elicits anti-Ebola seroconversion

January 26, 2017
Next Post
Comparison of treatment options for varicose veins [CLASS trial]

Comparison of treatment options for varicose veins [CLASS trial]

CTA as an alternative to angiography for blunt cerebrovascular trauma detection

Perfusion imaging may be useful for selecting stroke patients for thrombolysis

Admission may not be needed following sleep apnea surgery

Admission may not be needed following sleep apnea surgery

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
  • #VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension
  • High-dose exercise therapy is not superior to low-dose exercise therapy for knee osteoarthritis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options